Nicholas Segal, Director at TherapeuticsMD, Inc. (TXMD), bought 74,128 shares at $1.55 ($115K) on 2013-08-26, disclosed to the SEC on 2013-08-28.
Open-market purchase of $115k TXMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.